Vojo Deretic, Graham S Timmins. Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells. bioRxiv 2020.03.29.008631;
https://doi.org/10.1101/2020.03.29.008631
https://www.mediterranee-infection.com/wp-content/uploads/2020/04/Azithro_COVID.pdf
Liu J, Cao R, Xu M, et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6:16. Published 2020 Mar 18. doi:10.1038/s41421-020-0156-0
https://www.mediterranee-infection.com/wp-content/uploads/2020/03/OHCQ-Cell-discovery.pdf
Cao B, Wang Y, Wen D, et al. A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19 [published online ahead of print, 2020 Mar 18]. N Engl J Med. 2020;10.1056/NEJMoa2001282. doi:10.1056/NEJMoa2001282
https://www.mediterranee-infection.com/wp-content/uploads/2020/03/10.1056@NEJMoa2001282-1.pdf
R Matthew Chico & Daniel Chandramohan. Azithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy. Expert Opin. Drug Metab. Toxicol. (2011) 7(9):1153-1167
https://www.mediterranee-infection.com/wp-content/uploads/2020/03/Chico-2011.-Azithromycin-plus-chloroquine-combination-therapy-for-protection-against-malaria-and-STD-infections-in-pregnancy.pdf
